Standard Biotools Inc.

LAB

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001162194

SEC filings (opens in a new tab)

No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.

Q4 2025 vs. Q3 2025

How the institutions holding Standard Biotools Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of LAB: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	155	4	159	+8
Shares	285.8M	153.2K	302.7M	+17.0M (+6.0%)
Value	$371.5M	$198.8K	$387.4M	+$16.0M (+4.3%)

4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Standard Biotools Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to LAB in Q4 2025
Institution	Shares	Value	% of portfolio
Landscape Capital Management, L.L.C.	619,129	$792.5K	0.05%
QVIDTVM Management LLC	229,338	$293.6K	0.33%
Point72 Asset Management, L.P.	143,307	$183.4K	0.00%
HRT Financial LP	93,782	$120.0K	0.00%
Mercer Global Advisors Inc	50,987	$65.3K	0.00%
Gsa Capital Partners LLP	47,266	$61.0K	0.01%
Zinnia Wealth Advisory, LLC	38,802	$49.7K	0.05%
CIBC Asset Management Inc	25,439	$32.6K	0.00%
EntryPoint Capital, LLC	24,607	$31.5K	0.01%
M&T Bank Corp	23,908	$30.6K	0.00%
Aigen Investment Management, LP	22,169	$28.4K	0.01%
CIBC World Markets Corp	19,803	$25.3K	0.00%
Busey Wealth Management	15,594	$20.0K	0.00%
Global Retirement Partners, LLC	12,967	$16.6K	0.00%
Voleon Capital Management LP	10,350	$13.2K	0.00%
Sagewood Asset Management LP	10,271	$13.1K	0.00%
GAMMA Investing LLC	735	$941	0.00%
Keating Financial Advisory Services, Inc.	402	$515	0.00%
United Financial Planning Group LLC	250	$320	0.00%
Caitong International Asset Management Co., Ltd	165	$211	0.00%
YANKCOM Partnership	94	$120	0.00%
National Bank of Canada	2	$3	0.00%

Sold out (14)

Institutions that held Standard Biotools Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of LAB in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
JBF Capital, Inc.	770,654	$1.00M
Tang Capital Management LLC	407,755	$530.1K
GM Advisory Group, Inc.	300,000	$390.0K
Balyasny Asset Management LLC	86,005	$111.8K
HSBC Holdings PLC	45,685	$59.2K
Boothbay Fund Management, LLC	36,714	$47.7K
Teacher Retirement System of Texas	31,528	$41.0K
GTS Securities LLC	20,538	$26.7K
Pallas Capital Advisors LLC	10,576	$13.7K
Advisory Services Network, LLC	6,490	$8.44K
Fortitude Family Office, LLC	793	$1.03K
Rise Advisors, LLC	463	$602
Clearstead Advisors, LLC	215	$280
Wealthspire Advisors, LLC	200	$260

Not filed for Q4 2025 yet (4)

Institutions that held Standard Biotools Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LAB in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Abich Financial Wealth Management LLC	91,448	$118.9K
CIBC Bancorp USA Inc.	31,908	$41.5K
Takeda Pharmaceutical Co Ltd	16,515	$21.5K
Shell Asset Management Co	13,346	$17.0K